🔎 Trials Near Me

Hjem › Burkitts lymfom › New Jersey › Edison

Kliniske studier for Burkitts lymfom i Edison, NJ

5 studier for Burkitts lymfom søker deltakere på steder i og rundt Edison (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.

Offisiell studietekst (engelsk)

Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →

A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)

RekruttererFase 2
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
366 Days – 46 Years · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06124157

Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia

RekruttererFase 2
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
365 Days · Alle kjønn · Oppdatert 25. sep. 2026 · NCT06317662

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

RekruttererFase 1/2
  • Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick · 3 mi unna
6 Months – 25 Years · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06395103

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

RekruttererFase 2
  • Saint Peter's University Hospital, New Brunswick · 3 mi unna
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
  • Rutgers Cancer Institute of New Jersey, New Brunswick · 3 mi unna
Alder 1 til 30 · Alle kjønn · Oppdatert 1. sep. 2026 · NCT04546399

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

RekruttererFase 3
  • Saint Peter's University Hospital, New Brunswick · 3 mi unna
  • Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick · 3 mi unna
365 Days – 25 Years · Alle kjønn · Oppdatert 25. aug. 2026 · NCT03959085

Burkitts lymfom-studier i andre byer

Andre studier i Edison

Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.